Oppenheimer Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-26,200
| Closed | -$186K | – | 1524 |
|
|
2020
Q1 | $186K | Sell |
26,200
-3,996
| -13% | -$28.4K | ﹤0.01% | 984 |
|
|
2019
Q4 | $721K | Sell |
30,196
-3,287
| -10% | -$78.5K | 0.02% | 712 |
|
|
2019
Q3 | $898K | Buy |
33,483
+3,790
| +13% | +$102K | 0.02% | 644 |
|
|
2019
Q2 | $806K | Sell |
29,693
-2,941
| -9% | -$79.8K | 0.02% | 685 |
|
|
2019
Q1 | $1.13M | Buy |
32,634
+24,553
| +304% | +$852K | 0.03% | 575 |
|
|
2018
Q4 | $158K | Sell |
8,081
-574
| -7% | -$11.2K | ﹤0.01% | 1073 |
|
|
2018
Q3 | $231K | Buy |
8,655
+2,576
| +42% | +$68.8K | 0.01% | 1043 |
|
|
2018
Q2 | $230K | Buy |
+6,079
| New | +$230K | 0.01% | 1033 |
|
|
2017
Q4 | – | Sell |
-2,862
| Closed | -$155K | – | 1582 |
|
|
2017
Q3 | $155K | Buy |
2,862
+2,047
| +251% | +$111K | ﹤0.01% | 1102 |
|
|
2017
Q2 | $46K | Sell |
815
-240
| -23% | -$13.5K | ﹤0.01% | 1366 |
|
|
2017
Q1 | $41K | Buy |
+1,055
| New | +$41K | ﹤0.01% | 1389 |
|